Does TYSABRI Cause Central venous catheterisation? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Central venous catheterisation have been filed in association with TYSABRI. This represents 0.3% of all adverse event reports for TYSABRI.
22
Reports of Central venous catheterisation with TYSABRI
0.3%
of all TYSABRI reports
0
Deaths
2
Hospitalizations
How Dangerous Is Central venous catheterisation From TYSABRI?
Of the 22 reports, 2 (9.1%) required hospitalization.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TYSABRI. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does TYSABRI Cause?
Multiple sclerosis relapse (811)
Fatigue (759)
Malaise (523)
Gait disturbance (445)
Multiple sclerosis (443)
Memory impairment (422)
Headache (368)
Drug ineffective (329)
Asthenia (328)
Fall (324)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
Which TYSABRI Alternatives Have Lower Central venous catheterisation Risk?
TYSABRI vs TYVASO
TYSABRI vs UBIDECARENONE
TYSABRI vs UBLITUXIMAB
TYSABRI vs UBLITUXIMAB-XIIY
TYSABRI vs UBROGEPANT